The mechanism of cytotoxicity by Naja naja atra cardiotoxin 3 is physically distant from its membrane-damaging effect

Toxicon

Volumn 50, Issue 6, 2007, Pages 816-824

  Chen, Ku Chung ^a   Kao, Pei Hsiu ^a   Lin, Shinne Ren ^b   Chang, Long Sen ^a  

^a NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cardiotoxin; Cytotoxicity; Membrane damaging activity; Naja naja atra

Indexed keywords

CARDIOTOXIN; CARDIOTOXIN 3; LIPOCORTIN 5; PROPIDIUM IODIDE; SNAKE VENOM; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; CYTOTOXICITY TEST; DNA DEGRADATION; HUMAN; HUMAN CELL; MEMBRANE DAMAGE; PHOSPHOLIPID VESICLE; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CASPASES; CELL LINE, TUMOR; CELL SURVIVAL; COBRA; COBRA VENOMS; CYTOTOXINS; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LIPID BILAYERS; LIPOSOMES; MALE; MEMBRANE PROTEINS; OXIDATION-REDUCTION; PROSTATIC NEOPLASMS;

NAJA ATRA;

EID: 34548816458     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2007.06.011     Document Type: Article

References (31)

1. Bilwes A., Rees B., Moras D., Menez R., and Menez A. X-ray structure at 1.55 Å of toxin γ, a cardiotoxin from Naja nigricollis venom. Crystal packing reveals a model for insertion into membranes. J. Mol. Biol. 239 (1994) 122-136
2. Chang L.S., Chung C., Huang H.N., and Lin S.R. Purification and characterization of a chymotrypsin inhibitor from the venom of Ophiophagus hannah (King cobra). Biochem. Biophys. Res. Commun. 283 (2001) 862-867
3. Dufton M.J., and Hider R.C. The structure and pharmacology of elapid cytotoxins. In: Harvey A.L. (Ed). Snake Toxins (1991), Pergamon Press, New York 259-302
4. Feofanov A.V., Sharonov G.V., Astapova M.V., Rodionov D.I., Utkin Y.N., and Arseniev A.S. Cancer cell injury by cytotoxins from cobra venom is mediated through lysosomal damage. Biochem. J. 390 (2005) 11-18
5. Forouhar F., Huang W.N., Liu J.H., Chien K.Y., Wu W.G., and Hsiao C.D. Structural basis of membrane-induced cardiotoxin A3 oligomerization. J. Biol. Chem. 278 (2003) 21980-21988
6. Gatineau E., Toma F., Montenay-Garestier T., Takechi M., Fromageot P., and Menez A. Role of tyrosine and tryptophan residues in the structure-activity relationships of a cardiotoxin from Naja nigricollis venom. Biochemistry 26 (1987) 8046-8055
7. Gatineau E., Takechi M., Bouet F., Mansuelle P., Rochat H., Harvey A.L., Montenay-Garestier T., and Menez A. Delineation of the functional site of a snake venom cardiotoxin: preparation, structure, and function of monoacetylated derivatives. Biochemistry 29 (1990) 6480-6489
8. Hawley T.S., and Hawley R.G. Flow Cytometry Protocols (2004), Human Press, Totowa, NJ
9. Jayaraman G., Kumar T.K., Tsai C.C., Srisailam S., Chou S.H., Ho C.L., and Yu C. Elucidation of the solution structure of cardiotoxin analogue V from the Taiwan cobra (Naja naja atra), identification of structural features important for the lethal action of snake venom cardiotoxins. Protein Sci. 9 (2000) 637-646
10. Lecrone V., Li W., Devoll R.E., Logothetis C., and Farach-Carson M.C. Calcium signals in prostate cancer cells: specific activation by bone-matrix proteins. Cell Calcium 27 (2000) 35-42
11. Lin S.R., Chang L.S., and Chang K.L. Separation and structure-function studies of Taiwan cobra cardiotoxins. J. Protein Chem. 21 (2002) 81-86
12. Lundblad R.L. Techniques in Protein Modification (1995), CRC Press, Boca Raton, FL
13. Ma D., Armugam A., and Jeyaseelan K. Cytotoxic potency of cardiotoxin from Naja sputatrix: development of a new cytolytic assay. Biochem. J. 366 (2002) 35-43
14. Marchot P., Bougis P.E., Ceard B., Van Rietschoten J., and Rochat H. Localization of the toxic site of Naja mossambica cardiotoxins: small synthetic peptides express an in vivo lethality. Biochem. Biophys. Res. Commun. 153 (1988) 642-647
15. Nicol F., Nir S., and Szoka Jr. F.C. Effect of cholesterol and charge on pore formation in bilayer vesicles by a pH-sensitive peptide. Biophys. J. 71 (1996) 3288-3301
16. Nicol F., Nir S., and Szoka Jr. F.C. Effect of phospholipid composition on an amphipathic peptide-mediated pore formation in bilayer vesicles. Biophys. J. 78 (2000) 818-829
17. Patel H.V., Vyas A.A., Vyas K.A., Liu Y.S., Chiang C.M., Chi L.M., and Wu W.G. Heparin and heparan sulfate bind to snake cardiotoxin. Sulfated oligosaccharides as a potential target for cardiotoxin action. J. Biol. Chem. 272 (1997) 1484-1492
18. 2+-independent membrane-damaging activity. Biochem. J. 382 (2004) 191-198
19. Sivaraman T., Kumar T.K., Hung K.W., and Yu C. Influence of disulfide bonds on the induction of helical conformation in proteins. J. Protein Chem. 18 (1999) 481-488
20. Stevens-Truss R., and Hinman C.L. Chemical modification of methionines in a cobra venom cytotoxin differentiates between lytic and binding domains. Toxicol. Appl. Pharmacol. 139 (1996) 234-242
21. Stevens-Truss R., and Hinman C.L. Activities of cobra venom cytotoxins toward heart and leukemic T-cells depend on localized amino acid differences. Toxicon 35 (1997) 659-669
22. Su S.H., Su S.J., Lin S.R., and Chang K.L. Cardiotoxin-III selectively enhances activation-induced apoptosis of human CD8+ T lymphocytes. Toxicol. Appl. Pharmacol. 193 (2003) 97-105
23. Sue S.C., Chien K.Y., Huang W.N., Abraham J.K., Chen K.M., and Wu W.G. Heparin binding stabilizes the membrane-bound form of cobra cardiotoxin. J. Biol. Chem. 277 (2002) 2666-2673
24. Sun Y.J., Wu W.G., Chiang C.M., Hsin A.Y., and Hsiao C.D. Crystal structure of cardiotoxin V from Taiwan cobra venom: pH-dependent conformational change and a novel membrane-binding motif identified in the three-finger loops of P-type cardiotoxin. Biochemistry 36 (1997) 2403-2413
25. Urry D.W., Masotti L., and Krivacic J.R. Circular dichroism of biological membranes. I. Mitochondria and red blood cell ghosts. Biochim. Biophys. Acta 241 (1971) 600-612
26. Wang C.H., and Wu W.G. Amphiphilic β-sheet cobra cardiotoxin targets mitochondria and disrupts its network. FEBS Lett. 579 (2005) 3169-3174
27. Wang C.H., Monette R., Lee S.C., Morley P., and Wu W.G. Cobra cardiotoxin-induced cell death in fetal rat cardiomyocytes and cortical neurons: different pathway but similar cell surface target. Toxicon 46 (2005) 430-440
28. Wang C.H., Liu J.H., Lee S.C., Hsiao C.D., and Wu W.G. Glycosphingolipid-facilitated membrane insertion and internalization of cobra cardiotoxin. The sulfatide-cardiotoxin complex structure in a membrane-like environment suggests a lipid-dependent cell-penetrating mechanism for membrane binding polypeptides. J. Biol. Chem. 281 (2006) 656-667
29. Wu P.L., Lee S.C., Chuang C.C., Mori S., Akakura N., Wu W.G., and Takada Y. Non-cytotoxic cobra cardiotoxin A5 binds to αvβ3 integrin and inhibits bone resorption. Identification of cardiotoxins as non-RGD integrin-binding proteins of the Ly-6 family. J. Biol. Chem. 281 (2006) 7937-7945
30. Yan F.J., Chen C.P., Cheng Y.C., and Chang L.S. Mutagenesis studies on the N-terminus and Thr54 of Naja naja atra (Taiwan cobra) chymotrypsin inhibitor. Protein J. 25 (2006) 257-262
31. Yang S.H., Chien C.M., Lu M.C., Lin Y.H., Hu X.W., and Lin S.R. Up-regulation of Bax and endonuclease G, and down-modulation of Bcl-XL involved in cardiotoxin III-induced apoptosis in K562 cells. Exp. Mol. Med. 38 (2006) 435-444